Rahul Ballal - Insider Trading & Ownership

Location
116 Huntington Avenue, 6 Th Floor, Boston, MA
Summary
The estimated net worth of Rahul Ballal is at least $1.22M dollars as of August 13, 2025. Rahul Ballal is the Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $629K. Rahul Ballal is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $586K.
Signature
/s/ William Cook, as attorney-in-fact for Rahul Ballal
All Insider Reports
All Insider Reports

Ownership of Rahul Ballal

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN, IMRA Enliven Therapeutics, Inc. Director $629K -$294K -31.8% Feb 6, 2025
AGIO AGIOS PHARMACEUTICALS, INC. Director $586K -$1.12M -65.6% Aug 11, 2025

Insider Transactions Reported by Rahul Ballal:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.